Cary Pharmaceuticals
Business Identifier: NO Business Identifier is currently available for this company.
Public Profile:
Cary Pharmaceuticals is a pharmaceutical development company. The company is advancing the development of its two lead products, Tempol and QuitPak. Tempol will be a a treatment for chronic hypertension. It reduces oxidative stress by mimicking the function of superoxide dismutase (SOD), one of the body's natural antioxidant defense mechanisms. QuitPak® is an oral, non-nicotine product specifically designed for smoking cessation

 Synopsis: Awardee Business Condition
Year Founded IP Holdings
Employee Range VC funded?
Revenue Range Private/Public
 Most Recent SBIR Projects
Year Phase Agency Dollars Project Title
A Novel Combination Therapy for Smoking Cessation